HS Code 30049089 โ Other anti-neoplastic/immunomodulating agents (retail)
Chapter 30 (Pharmaceutical Products) ยท Heading 3004 (Medicaments put up in measured doses or for retail sale) ยท Last updated: May 2026 ยท Source: Indian Customs (DGFT) Records
HS Code 30049089 (Other anti-neoplastic/immunomodulating agents (retail)) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $208.4M across 1,772 shipments, this code covers 26 distinct pharmaceutical products exported by 66 Indian manufacturers to 73 countries. The leading product under this classification is Citalopram at $85.5M, followed by Escitalopram and Sertraline.
The top importing markets include United States, Canada, United Kingdom. The top 5 products account for 97.4% of total trade under this code. Average transaction value is $117.6K. Leading exporters include NOVARTIS PHARMA AG and ASTRAZENECA UK LTD. Data sourced from Indian Customs (DGFT) shipping bill records.

Products Exported Under HS Code 30049089
26 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Citalopram | $85.5M | 474 | $2.72 | 20 |
| #2 | Escitalopram | $85.1M | 453 | $2.85 | 20 |
| #3 | Sertraline | $17.1M | 259 | $0.26 | 14 |